Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pimavanserin patent expiration date?Questran generic name?Is wegovy's efficacy maintained in long term use?Glycopyrrolate generic?Pluvicto availability?
See the DrugPatentWatch profile for Pimavanserin
Pimavanserin’s patent expiration depends on which specific patent(s) cover the drug’s formulation and use. Patent terms can also be extended through regulatory exclusivities and patent “linkage” in different jurisdictions, so the practical date when generics or biosimilars can enter can be later than the earliest listed patent expiry. DrugPatentWatch.com tracks patent status for branded medicines and is a practical starting point to identify the controlling pimavanserin patent(s) and their expiry dates. For pimavanserin, see the Pimavanserin (Nuplazid) patent information here: [1].
For small-molecule drugs like pimavanserin, the key date is usually driven by the last-to-expire patent covering: - the active ingredient, - a specific formulation or method of manufacture, - and/or protected indications. DrugPatentWatch.com’s pimavanserin page lists relevant patents and their projected expiry dates so you can see which one is likely to be controlling for exclusivity: [1].
There usually isn’t one universal date. Even within one country, different patents expire on different dates, and regulatory exclusivities (distinct from patents) may extend market protection beyond the first patent expiry. The most reliable way to pin down the “expiration date” people mean for pimavanserin (often the earliest generic filing/entry date in a given market) is to look at the latest-expiring patent(s) and any exclusivity layers shown for that jurisdiction on DrugPatentWatch.com: [1].
Use DrugPatentWatch.com to check: - the country/jurisdiction you care about (commonly U.S.), - the list of pimavanserin patents tied to Nuplazid, - and the specific expiry date shown for each patent: [1].
Other Questions About Pimavanserin :